Alexander, G. Caleb Ogasawara, Ken Wiegand, Dana Lin, Dora Breder, Christopher D. Supplemental Material, 812058_web_appendix - Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016 <p>Supplemental Material, 812058_web_appendix for Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016 by G. Caleb Alexander, Ken Ogasawara, Dana Wiegand, Dora Lin, and Christopher D. Breder in Therapeutic Innovation & Regulatory Science</p> drug approval;regulatory affairs;expedited programs 2019-11-26
    https://sage.figshare.com/articles/journal_contribution/Supplemental_Material_812058_web_appendix_-_Clinical_Development_of_Biologics_Approved_by_the_US_Food_and_Drug_Administration_2003-2016/7441256
10.25384/SAGE.7441256.v2